Alzheimer's blood-based biomarkers, incident dementia, and interactions with age, APOE status, and hormone therapy. | ClinicLens
Cognitive impairment among older adults is often due to multiple pathologies and heterogenous risk factors. We assessed whether Alzheimer's blood-based biomarkers (BBMs) were associated with incident mild cognitive impairment (MCI)/probable dementia, and whether associations
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.